Hydrochloric Acid → HCID 71737241, compound
Reaction equation
C([Si](C1C=CC=CC=1)(C1C=CC=CC=1)[O:6][CH:7]1[CH2:12][CH2:11][N:10]([CH2:13][C:14]2[CH:19]=[CH:18][C:17]([C:20]3[NH:21][C:22](=[O:31])[C:23]4[C:28]([CH:29]=3)=[C:27]([CH3:30])[CH:26]=[CH:25][CH:24]=4)=[CH:16][CH:15]=2)[CH2:9][CH2:8]1)(C)(C)C.Cl>C(Cl)Cl>[OH:6][CH:7]1[CH2:12][CH2:11][N:10]([CH2:13][C:14]2[CH:19]=[CH:18][C:17]([C:20]3[NH:21][C:22](=[O:31])[C:23]4[C:28]([CH:29]=3)=[C:27]([CH3:30])[CH:26]=[CH:25][CH:24]=4)=[CH:16][CH:15]=2)[CH2:9][CH2:8]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a stirred solution of 3-{4-[4-(tert-butyl-diphenyl-silanyloxy)-piperidin-1-ylmethyl]-phenyl}-5-methyl-2H-isoquinolin-1-one (213 mg, 0.36 mmol) in CH2Cl2 (2 mL) was added 1.25M methanolic HCl (1 mL) and the reaction stirred at RT for 48 h. The reaction mixture was concentrated in vacuo and the crude residue purified by reverse phase preparative HPLC-MS to afford 3-[4-(4-hydroxy-piperidin-1-ylmethyl)-phenyl]-5-methyl-2H-isoquinolin-1-one as a pale yellow solid (80 mg, 64%).
Workup
- concentrationThe reaction mixture was concentrated in vacuo
- customthe crude residue purified by reverse phase preparative HPLC-MS
Sources & evidence
- ORD record
- ord-05583d8afb4f4aedbee143c8bf8ce6c0
- Source dataset
- uspto-grants-2015_11
- Patent number
- US09193689B2
Reaction notes
Loading…